Tetsuhiro Tanaka & Masaomi Nangaku. (2009). Drug Discovery for Overcoming Chronic Kidney Disease (CKD): Prolyl-Hydroxylase Inhibitors to Activate Hypoxia-Inducible Factor (HIF) as a Novel Therapeutic Approach in CKD. Elsevier.
Chicago Style (17th ed.) CitationTetsuhiro Tanaka and Masaomi Nangaku. Drug Discovery for Overcoming Chronic Kidney Disease (CKD): Prolyl-Hydroxylase Inhibitors to Activate Hypoxia-Inducible Factor (HIF) as a Novel Therapeutic Approach in CKD. Elsevier, 2009.
MLA (9th ed.) CitationTetsuhiro Tanaka and Masaomi Nangaku. Drug Discovery for Overcoming Chronic Kidney Disease (CKD): Prolyl-Hydroxylase Inhibitors to Activate Hypoxia-Inducible Factor (HIF) as a Novel Therapeutic Approach in CKD. Elsevier, 2009.
Warning: These citations may not always be 100% accurate.